BAAM
CLB icon

Baker Avenue Asset Management’s Core Laboratories CLB Stock Holding History

Baker Avenue Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-49
Closed -$1.18K – 573
2023
Q3 		$1.18K Hold
49
– – ﹤0.01% 1241
2023
Q2 		$1.14K Hold
49
– – ﹤0.01% 1137
2023
Q1 		$1.08K Hold
49
– – ﹤0.01% 1157
2022
Q4 		$993 Buy
+49
New +$950 ﹤0.01% 1102

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baker Avenue Asset Management's CLB Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Core Laboratories (CLB) in Q4 2023, closing a stake of 49 shares — an estimated $1.18K sold.

Baker Avenue Asset Management first reported a position in CLB in Q4 2022 and held it in 4 quarters. The position peaked at $1.18K in Q3 2023. 186 funds tracked by Wall St. Rank hold CLB as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Core Laboratories position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 49 Core Laboratories shares in Q4 2023, an estimated $1.18K.
  • Baker Avenue Asset Management first reported a position in Core Laboratories in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's Core Laboratories position peaked at $1.18K in Q3 2023.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.